Observational studyJournal for immunotherapy of cancer2021

Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma.

Rebecca Pokorny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.